Using conjoint analysis to measure the acceptability of rectal microbicides among men who have sex with men in four south american cities

AIDS and Behavior

Volumn 16, Issue 6, 2012, Pages 1436-1447

  Kinsler, Janni J ^a   Cunningham, William E ^a   Nureña, César R ^b   Nadjat Haiem, Carsten ^c   Grinsztejn, Beatriz ^d   Casapia, Martin ^e   Montoya Herrera, Orlando ^f   Sánchez, Jorge ^g   Galea, Jerome T ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Funda??o Oswaldo Cruz   (Brazil)

^e ASOCIACIÓN CIVIL SELVA AMAZÓNICA   (Peru)

^f Fundacion Ecuatoriana Equidad   (Ecuador)

^g ASOCIACIÓN CIVIL IMPACTA SALUD Y EDUCACIÓN   (Peru)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acceptability; Conjoint analysis; HIV; MSM; Rectal microbicides

Indexed keywords

ANTIINFECTIVE AGENT; LUBRICATING AGENT;

ADOLESCENT; ADULT; ARTICLE; CONSUMER; FINANCIAL MANAGEMENT; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; PATIENT ATTITUDE; RECTAL DRUG ADMINISTRATION; SOCIOECONOMICS; SOUTH AMERICA; STATISTICAL MODEL; STATISTICS; URBAN POPULATION;

ADMINISTRATION, RECTAL; ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; CONSUMER PARTICIPATION; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; LUBRICANTS; MALE; MARKETING OF HEALTH SERVICES; MIDDLE AGED; MODELS, STATISTICAL; PATIENT ACCEPTANCE OF HEALTH CARE; SOCIOECONOMIC FACTORS; SOUTH AMERICA; URBAN POPULATION; YOUNG ADULT;

EID: 84865185589     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-011-0045-5     Document Type: Article

References (50)

1. Q Abdool Karim SS Abdool Karim JA Frohlich, et al. 2010 Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Science 329 5996 1168 1174 20643915 10.1126/science. 1193748 1:CAS:528:DC%2BC3cXhtV2hsr%2FI
2. RM Grant JR Lama PL Anderson, et al. 2010 Preexposure chemoprophylaxis for HIV prevention in men who have sex with men N Engl J Med 363 27 2587 2599 21091279 10.1056/NEJMoa1011205 1:CAS:528:DC%2BC3MXit1ansg%3D%3D
3. University of Washington International Clinical Research Center: partners PrEP study. Pivotal study finds that HIV medications are highly effective as prophylaxis against HIV infection in men and women in Africa. 2011; Available at: http://depts.washington.edu/uwicrc/research/studies/files/PrEP-PressRelease- UW-13Jul2011.pdf. Accessed 15 July 2011.
4. Centers for Disease Control and Prevention. CDC trial and another major study find PrEP can reduce risk of HIV infection among Heterosexuals. 2011. Available at: http://www.cdc.gov/nchhstp/newsroom/PrEPHeterosexuals.html. Accessed 15 July 2011.
5. NS Joglekar SN Joshi SS Deshpande AN Parkhe UR Katti SM Mehendale 2010 Acceptability and adherence: findings from a Phase II study of a candidate vaginal microbicide, 'Praneem polyherbal tablet', in Pune, India Trans R Soc Trop Med Hyg 104 6 412 415 20096909 10.1016/j.trstmh.2009.12.007 1:STN:280:DC%2BC3czitl2lsw%3D%3D
6. I McGowan 2011 Rectal microbicides: can we make them and will people use them? AIDS Behav 15 Suppl 1 S66 S71 21331798 10.1007/s10461-011-9899-9
7. International Rectal Microbicides Advocates (IRMA). From promise to product: advancing rectal microbicide research and advocacy, Chicago; 2010.
8. A Carballo-Diéguez C Dolezal JA Bauermeister W O'Brien A Ventuneac K Mayer 2008 Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men Sex Transm Infect 84 6 483 487 19028952 10.1136/sti.2008.030478
9. A Carballo-Diéguez JA Bauermeister A Ventuneac C Dolezal I Balan RH Remien 2008 The use of rectal douches among HIV-uninfected and infected men who have unprotected receptive anal intercourse: implications for rectal microbicides AIDS Behav 12 6 860 866 17705033 10.1007/s10461-007-9301-0
10. A Carballo-Diéguez J Bauermeister A Ventuneac C Dolezal K Mayer 2009 Why rectal douches may be acceptable rectal-microbicide delivery vehicles for men who have sex with men Sex Transm Dis 37 4 228 229
11. J Carroll P Green 1995 Psychometric methods in marketing research: part I, conjoint analysis J Mark Res XXXII 385 389 10.2307/3152174
12. P Green V Rao 1971 Conjoint measurement for quantifying judgmental data J Mark Res 8 3 355 363 10.2307/3149575
13. P Green V Srinivasan 1990 Conjoint analysis in marketing research: new developments and directions J Mark Res 54 3 19
14. P Marshall E Bradlow 2002 A unified approach to conjoint analysis models J Am Stat Assoc 97 459 674 682 10.1198/016214502388618410
15. KM Beusterien K Dziekan E Flood G Harding JC Jordan 2005 Understanding patient preferences for HIV medications using adaptive conjoint analysis: feasibility assessment Value Health 8 4 453 461 16091022 10.1111/j.1524-4733. 2005.00036.x (Pubitemid 41726098)
16. B Akkazieva L Gulacsi A Brandtmuller M Pentek JF Bridges 2006 Patients' preferences for healthcare system reforms in Hungary: a conjoint analysis Appl Health Econ Health Policy 5 3 189 198 17132033 10.2165/00148365-200605030-00005 (Pubitemid 46998490)
17. M Aristides J Chen M Schulz E Williamson S Clarke K Grant 2002 Conjoint analysis of a new chemotherapy: willingness to pay and preference for the features of raltitrexed versus standard therapy in advanced colorectal cancer Pharmacoeconomics 20 11 775 784 12201796 10.2165/00019053-200220110-00006 (Pubitemid 35034445)
18. JS Bhargava A Bhan-Bhargava AJ Foss AJ King 2008 Views of glaucoma patients on provision of follow-up care; an assessment of patient preferences by conjoint analysis Br J Ophthalmol 92 12 1601 1605 18664502 10.1136/bjo.2008. 140483 1:STN:280:DC%2BD1cjlsFCjuw%3D%3D
19. D Bishai R Brice I Girod A Saleh J Ehreth 2007 Conjoint analysis of French and German parents' willingness to pay for meningococcal vaccine Pharmacoeconomics 25 2 143 154 17249856 10.2165/00019053-200725020-00006 (Pubitemid 46175550)
20. AJ Bishop TM Marteau D Armstrong, et al. 2004 Women and health care professionals' preferences for Down's syndrome screening tests: a conjoint analysis study BJOG 111 8 775 779 15270923 10.1111/j.1471-0528.2004.00197.x (Pubitemid 39061498)
21. ML Costa K de Cassia Braga Ribeiro MA Machado AC Costa AL Montagnini 2006 Prognostic score in gastric cancer: the importance of a conjoint analysis of clinical, pathologic, and therapeutic factors Ann Surg Oncol 13 6 843 850 16614885 10.1245/ASO.2006.05.040 (Pubitemid 43727369)
22. CE Cunningham K Deal H Rimas Y Chen DH Buchanan K Sdao-Jarvie 2009 Providing information to parents of children with mental health problems: a discrete choice conjoint analysis of professional preferences J Abnorm Child Psychol 37 8 1089 1102 19629676 10.1007/s10802-009-9338-9
23. K Fisher F Orkin C Frazer 2010 Utilizing conjoint analysis to explicate health care decision making by emergency department nurses: a feasibility study Appl Nurs Res 23 1 30 35 20122508 10.1016/j.apnr.2008.03.004
24. M Ryan S Farrar 2000 Using conjoint analysis to elicit preferences for health care BMJ 320 7248 1530 1533 10834905 10.1136/bmj.320.7248.1530 1:STN:280:DC%2BD3c3psV2msA%3D%3D (Pubitemid 30330316)
25. EJ Lancsar JP Hall M King, et al. 2007 Using discrete choice experiments to investigate subject preferences for preventive asthma medication Respirology 12 1 127 136 17207038 10.1111/j.1440-1843.2006.01005.x (Pubitemid 44968212)
26. VE Stone J Jordan J Tolson R Miller T Pilon 2004 Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence J Acquir Immune Defic Syndr 36 3 808 816 15213564 10.1097/00126334-200407010-00007 (Pubitemid 38859346)
27. PA Newman N Duan SJ Lee, et al. 2006 HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics Vaccine 24 12 2094 2101 16332402 10.1016/j.vaccine.2005.11.013 (Pubitemid 43255152)
28. J Galea J Kinsler X Salazar, et al. 2010 Acceptability of pre-exposure prophylaxis (PrEP) as an HIV prevention strategy: barriers and facilitators to PrEP uptake among at-risk Peruvian populations Int J STD AIDS 22 256 262 10.1258/ijsa.2009.009255
29. E Lancsar E Savage 2004 Deriving welfare measures from discrete choice experiments: inconsistency between current methods and random utility and welfare theory Health Econ 13 9 901 907 15362181 10.1002/hec.870 (Pubitemid 39264236)
30. Hunink M, Glasziou P, Siegel J, et al. Decision making in health and medicine: integrating evidence and values. Cambridge: Cambridge University Press; 2001.
31. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva: UNAIDS. Accessed 10 April 2011.
32. S Baral F Sifakis F Cleghorn C Beyrer 2007 Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000-2006: a systematic review PLoS Med 4 12 e339 18052602 10.1371/journal.pmed. 0040339
33. RH Gray MJ Wawer R Brookmeyer, et al. 2001 Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda Lancet 357 9263 1149 1153 11323041 10.1016/S0140- 6736(00)04331-2 1:STN:280:DC%2BD3MzisFejug%3D%3D (Pubitemid 32378686)
34. E Vittinghoff J Douglas F Judson D McKirnan K MacQueen SP Buchbinder 1999 Per-contact risk of human immunodeficiency virus transmission between male sexual partners Am J Epidemiol 150 3 306 311 10430236 10.1093/oxfordjournals. aje.a010003 1:STN:280:DyaK1Mzlslejtw%3D%3D (Pubitemid 29344958)
35. Foss A, Johnson H, Prudden H, et al. Modelling the potential impact on HIV transmission of a rectal microbicide used by men who have sex with men and the effects of condom substitution. Microbicides. Pittsburgh, 2010 [abstract WEPE0340].
36. Sánchez J. Cutting the edge of the HIV epidemic among MSM. Presented at: The Center for HIV Identification, Prevention, and Treatment Services (CHIPTS). The future direction of male circumcision in HIV prevention working conference; April 9, 2007; Los Angeles. http://chipts.ucla.edu/TEMPMAT/ MaleCirc2007/Sanchez%20LA.pdf. Accessed 15 July 2011.
37. WR Holmes L Maher SL Rosenthal 2008 Attitudes of men in an Australian male tolerance study towards microbicide use Sex Health 5 3 273 278 18771643 10.1071/SH07093
38. Orme B. Getting started with conjoint analysis: strategies for product design and pricing research. 2nd ed. Madison: Research Publishers LLC; 2010.
39. A Carballo-Diéguez T Exner C Dolezal R Pickard P Lin KH Mayer 2007 Rectal microbicide acceptability: results of a volume escalation trial Sex Transm Dis 34 4 224 229 16906126 10.1097/01.olq.0000233715.59239.83 (Pubitemid 46606747)
40. Pickett J, LeBlanc MA, Gorbach P, Murphy R, Javanbakht M. International lubricant use behaviors for anal intercourse. XVII international AIDS conference. Mexico City, 2008. [abstract WEPE0275].
41. Anton P, Saunders T, Adler A, et al. A phase 1 safety and acceptability study of the UC-781 microbicide gel applied rectally in HIV seronegative adults: an interim safety report at 50% completion. Microbicides. New Delhi, 2008. [abstract BO5-290].
42. JJ Kinsler JT Galea J Peinado P Segura SM Montano J Sánchez 2010 Lubricant use among men who have sex with men reporting receptive anal intercourse in Peru: implications for rectal microbicides as an HIV prevention strategy Int J STD AIDS 21 8 567 572 20975090 10.1258/ijsa.2010.010134 1:STN:280:DC%2BC3cbitFaqsQ%3D%3D
43. Anton P, Cranston R, Carballo-Diéguez A, et al. RMP-02/MTN-006: a phase 1 placebo-controlled trial of rectally applied 1% vaginal TFV gel with comparison to oral TDF. The 18th conference on retroviruses and opportunistic infections, Boston, USA; 2011.
44. Galea J, Kinsler J, Segura P, Peinado J, Sánchez J. The use of rectal douches among peruvian MSM: implications for rectal microbicides. Microbicides, Pittsburgh, 2010. [abstract 162].
45. EJ Saethre J Stadler 2010 Gelling medical knowledge: innovative pharmaceuticals, experience, and perceptions of efficacy Anthropol Med 17 1 99 111 20419520 10.1080/13648470903569396
46. JG Vail JA Cohen KL Kelly 2004 Improving topical microbicide applicators for use in resource-poor settings Am J Public Health 94 7 1089 1092 15226124 10.2105/AJPH.94.7.1089 (Pubitemid 38857304)
47. JA Cohen MS Steele FI Urena ME Beksinska 2007 Microbicide applicators: understanding design preferences among women in the dominican republic and South Africa Sex Transm Dis 34 1 15 19 16691157 10.1097/01.olq.0000218877.92778.fe (Pubitemid 46041502)
48. MM Cassell DT Halperin JD Shelton D Stanton 2006 Risk compensation: the Achilles' heel of innovations in HIV prevention? BMJ 332 7541 605 607 16528088 10.1136/bmj.332.7541.605 (Pubitemid 44365764)
49. SD Pinkerton 2001 Sexual risk compensation and HIV/STD transmission: empirical evidence and theoretical considerations Risk Anal 21 4 727 736 11726023 10.1111/0272-4332.214146 1:STN:280:DC%2BD3MnnvFGltA%3D%3D (Pubitemid 34101539)
50. PA Newman N Duan ET Rudy KJ Roberts D Swendeman 2004 Posttrial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk for HIV J Acquir Immune Defic Syndr 37 3 1393 1403 15483469 10.1097/01.qai. 0000127064.84325.ad (Pubitemid 39435054)